Biotech Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause October 10, 2024
Biotech Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients October 10, 2024
Biotech Antag Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Lead Molecule, AT-7687 October 9, 2024
Biotech BioCorteX Unveils Critical Bacteria Interactions in ADC Cancer Treatment, Enabled by Google Cloud October 9, 2024
Biotech CTC ━ Centro De Tecnologia Canavieira Engages SC Solutions To Provide AI Technology for Sugarcane October 8, 2024
Biotech Adcendo Announces US FDA Clearance of IND Application for Phase I/II First-in-Human ADCElerate-01 Trial of ADCE-D01 (uPARAP Receptor Targeting ADC) Trial in Patients With Metastatic and/or Unresectable Soft Tissue Sarcoma (STS) October 8, 2024
Biotech Clean Food Group partners with THG LABS to harness the power of cutting-edge oils and fats technology powered by food waste, to drive innovation and sustainability in the cosmetics industry October 8, 2024
Biotech BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients October 7, 2024
Biotech Lesaffre strengthens its Research, Development & Innovation (RD&I) with the acquisition of Altar, a company owned by Ginkgo Bioworks October 7, 2024